SCHEMBL631574

SCHEMBL631574

c1ccc(N(Cc2c[nH]cn2)c2ccccc2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 8/20 0.46
KCNA3 P22001 1/20 0.33
HDAC1 Q13547 1/20 0.33
HDAC8 Q9BY41 1/20 0.33
HDAC6 Q9UBN7 1/20 0.33
MAPT P10636 1/20 0.33
CRHBP P24387 1/20 0.33
CRHR2 Q13324 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
ALDH1A1 P00352 1/20 0.32
HTT P42858 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
CYP2D6 P10635 1/20 0.32
TSHR P16473 1/20 0.32
NR3C2 P08235 1/20 0.31
LMNA P02545 1/20 0.31
GLA P06280 1/20 0.31
BLM P54132 1/20 0.31
PMP22 Q01453 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL631933 0.80 TAAR1 (0.46) TAAR1MAPTCRHBPCRHR2NPSR1
SCHEMBL631366 0.72 SLC6A3 (0.33) TAAR1CYP2D6TSHRLMNACYP1A2
SCHEMBL631672 0.71 TAAR1 (0.41) TAAR1MAPTCRHBPCRHR2CYP2D6
SCHEMBL4370206 0.71 MAPT (0.59) TAAR1MAPTNPSR1ALDH1A1SMN1; SMN2
SCHEMBL649075 0.71 ALDH1A1 (0.46) TAAR1ALDH1A1L3MBTL1CYP2D6TSHR
SCHEMBL29662047 0.70 TAAR1 (0.42) TAAR1KCNA3HDAC1HDAC8HDAC6
SCHEMBL522565 0.70 KCNH2 (0.45) TAAR1KCNA3HDAC1HDAC8HDAC6
SCHEMBL14837521 0.69 TRPM8 (0.38) HDAC1HDAC8MAPTNPSR1ALDH1A1
SCHEMBL1753940 0.69 KCNH2 (0.50) TAAR1ALDH1A1LMNA
Toluene SCHEMBL28536406 0.69 LMNA (0.39) TSHRLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8586617-B2 Aminomethyl-4-imidazoles HOFFMANN-LA ROCHE INC. (US) 2013-11-19 US disclosed
EP-2076497-B1 AMINOMETHYL-4-IMIDAZOLES HOFFMANN LA ROCHE (CH) 2012-02-22 EP disclosed
EP-2076497-A1 AMINOMETHYL-4-IMIDAZOLES F. Hoffmann-Roche AG (CH) 2009-07-08 EP disclosed
US-20080119535-A1 AMINOMETHYL-4-IMIDAZOLES F. HOFFMANN-LA ROCHE AG (CH) 2008-05-22 US disclosed
WO-2008046757-A1 AMINOMETHYL-4-IMIDAZOLES F. HOFFMANN-LA ROCHE AG (CH) 2008-04-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080119535-A1 AMINOMETHYL-4-IMIDAZOLES INMT, HTR4, MC4R TAAR1 419/4885KCNA3 746/4885HDAC1 423/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.